| L03AA13 |
Pegfilgrastim |
Pelgraz |
Solution for injection |
10 mg/ml-0.6 ml |
|
1 prefilled syringe with needle guard + 1 alcohol swab |
Accord Healthcare Limited, Обединено Кралство |
0.3 |
mg |
1236.5 |
53.2045 |
1064.09 |
100% |
|
Съгласно РУ |
НСР-18048/01.03.2019 |
02.04.2019 |
|
Активен |
16452 |
| L03AA13 |
Pegfilgrastim |
Pelmeg |
Solution for injection |
10 mg/ml-0.6 ml (6 mg) |
|
1 prefilled syringe |
Mundipharma Biologics S.L., Испания |
0.3 |
mg |
1064.09 |
53.2045 |
1064.09 |
100% |
|
Съгласно РУ |
НСР-18449/15.04.2019 предварително изпълнение; НСР-20715/24.01.2020 |
02.03.2020 |
|
Активен |
16478 |
| L03AA13 |
Pegfilgrastim |
Ziextenzo |
Solution for injection |
10 mg/ml – 0.6 ml |
|
1 prefilled syringe |
Sandoz GmbH, Австрия |
0.3 |
mg |
1064.09 |
53.2045 |
1064.09 |
100% |
|
Съгласно РУ |
НСР-18049/01.03.2019 |
02.04.2019 |
|
Активен |
16451 |
| L03AA14 |
Lipegfilgrastim |
L03AA14 Lipegfilgrastim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AA14 |
Lipegfilgrastim |
Lonquex |
Solution for injection |
6 mg/0,6 ml |
|
1 pre-filled syringe with safety device |
Teva B.V., Нидерландия |
0.3 |
mg |
1231.78 |
61.589 |
1231.78 |
100% |
|
Съгласно РУ |
НСР-3771/16.06.2014; НСР-7482/12.11.2015; НСР-11350/30.12.2016 г.; КП-5/24.01.2018 и НСР-14271/26.10.2017; НСР-17288/16.11.2018 предварително изпълнение; НСР-18564/25.04.2019 |
02.06.2019 |
|
Активен |
2930 |
| L03AB04 |
Interferon alfa-2a |
L03AB04 Interferon alfa-2a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB04 |
Interferon alfa-2a |
Roferon-A |
solution for injection pre-filled syringe + needle |
3 |
MIU |
1 |
Рош България ЕООД, България |
2 |
MIU |
23.83 |
15.88667 |
23.83 |
100% |
|
Съгласно РУ |
КЦРР-924/04.07.2012 г. КЦРР-1418/05.09.2012;НСР-516/11.07.2013; НСР-2936/07.03.2014; Протокол 82/11.09.2014; НСР-5073/21.11.2014; НСР-6840/30.07.2015.; НСР-15355/30.03.2018 |
02.05.2018 |
08.09.2012 |
Активен |
3362 |
| L03AB05 |
Interferon alfa - 2b |
L03AB05 Interferon alfa - 2b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB05 |
Interferon Alfa-2b |
Realdiron |
Powder for solution for injection |
3 |
MIU |
5 |
Sicor Biotech UAB, Литва |
2 |
MIU |
76.4 |
10.18667 |
76.4 |
100% |
|
Съгласно РУ |
НСР-3216/14.04.2014 |
16.05.2014 |
08.09.2012 |
Заличен |
660 |
| L03AB08 |
Interferon beta-1b |
L03AB08 Interferon beta-1b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB08 |
Interferon beta-1b |
Betaferon |
Powder and solvent for solution for injection |
9.6 |
MIU |
15 vials + 15 pre-filled syringe |
Bayer AG, Германия |
4 |
MIU |
1401.96 |
30.57306 |
1100.63 |
100% |
|
Съгласно РУ |
№ 178/ 22.06.2011; КЦРР-2959/20.03.2013 г; НСР-2256/21.12.2013; НСР-5755/26.02.2015; НСР-9117/27.04.2016; НСР-13275/20.07.2017; Протокол №265/08.02.2018; НСР-16880/28.09.2018 |
02.11.2018 |
08.09.2012 |
Активен |
3629 |
| L03AB08 |
Interferon beta-1b |
Extavia |
Powder and solvent for solution for injection |
9.6 |
MIU |
15 |
Novartis Europharm Limited, Ирландия |
4 |
MIU |
1100.63 |
30.57306 |
1100.63 |
100% |
|
Съгласно РУ |
№ 178/ 22.06.2011; КЦРР-2188/06.02.2013 г; НСР-1733/21.11.2013; НСР-4537/22.08.2014; НСР-7473/12.11.2015; НСР-14793/10.01.2018; Протокол №265/08.02.2018; НСР-16305/27.07.2018 |
02.09.2018 |
08.09.2012 |
Активен |
3155 |
| L03AB10 |
Peginterferon |
L03AB10 Peginterferon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
80 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
268.76 |
24.61515 |
262.64 |
100% |
|
Съгласно РУ |
№35/21.08.2009; №39/27.08.2009; КЦPP-1149/02.08.2012; КЦРР-2285/20.02.2013 г; НСР-1977/06.12.2013; НСР-4300/05.08.2014; НСР-5829/19.03.2015; НСР-9398/01.06.2016; НСР-11971/10.03.2017; НСР-12763/19.05.2017 |
02.07.2017 |
08.09.2012 |
Заличен |
3695 |
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
100 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
328.12 |
24.61515 |
328.12 |
100% |
|
Съгласно РУ |
№35/21.08.2009; №39/27.08.2009; КЦPP-1149/02.08.2012; КЦРР-2284/20.02.2013 г; НСР-1977/06.12.2013; НСР-4301/05.08.2014; НСР-12213/03.04.2017; НСР-12761/19.05.2017 |
02.07.2017 |
08.09.2012 |
Заличен |
3140 |
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
120 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
394.58 |
24.61515 |
393.84 |
100% |
|
Съгласно РУ |
№35/21.08.2009; №39/27.08.2009; КЦPP-1635/15.11.2012; КЦРР-2283/20.02.2013 г; НСР-1977/06.12.2013; НСР-4302/05.08.2014; НСР-5830/19.03.2015; НСР-9397/01.06.2016; НСР-11970/10.03.2017 г.; НСР-12762/19.05.2017 |
02.07.2017 |
08.09.2012 |
Заличен |
3694 |
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
150 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
501.02 |
24.61515 |
492.3 |
100% |
|
Съгласно РУ |
КЦPP-2419/22.02.2013; НСР-5063/18.11.2014; НСР-8251/22.02.2016; НСР-10807/03.11.2016; НСР-12760/19.05.2017 |
02.07.2017 |
|
Заличен |
3366 |
| L03AB11 |
Peginterferon alfa-2a |
L03AB11 Peginterferon alfa-2a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB11 |
Peginterferon alfa-2a |
Pegasys |
Solution for injection |
135 mсg/0,5 ml |
|
1 pre-filled syringe + 1 injection needle |
Roche Registration GmbH, Германия |
26 |
mсg |
281.14 |
46.11272 |
239.33 |
100% |
|
Съгласно РУ |
№25/03.08.2009; №35/21.08.2009; №39/27.08.2009; № 238/ 04.11.2011; КЦРР-192/08.02.2012 г.; КЦРР-2734/20.03.2013 г.НСР-2314/13.01.2014; НСР-4813/ 13.10.2014.; НСР-6425/12.06.2015.; НСР-15758/25.05.2018 |
02.12.2018 |
08.09.2012 |
Активен |
3252 |
| L03AB11 |
Peginterferon alfa-2a |
Pegasys |
Solution for injection |
180 mcg/0,5 ml |
|
1 pre-filled syringe + 1 injection needle |
Roche Registration GmbH, Германия |
26 |
mсg |
319.1 |
46.11272 |
319.1 |
100% |
|
Съгласно РУ |
№25/03.08.2009.; №35/21.08.2009; №39/27.08.2009; КЦРР-628/18.05.2012 г.; НСР-972/12.08.2013; НСР-4864/17.10.2014; НСР-6542/24.06.2015; НСР-8434/07.03.2016; НСР-15756/25.05.2018; НСР-17070/26.10.2018 |
02.12.2018 |
08.09.2012 |
Активен |
3302 |
| L03AB11 |
Peginterferon alfa-2a |
Pegasys |
Solution for injection |
135 mсg/0,5 ml |
|
1 pre-filled pen |
Roche Registration Limited, Обединено Кралство |
26 |
mсg |
281.14 |
46.73121 |
242.54 |
100% |
|
Съгласно РУ |
КЦРР-960/16.07.2012 г.; НСР-438/09.07.2013; НСР-5934/01.04.2015.; НСР-12765/19.05.2017 |
02.07.2017 |
08.09.2012 |
Заличен |
3770 |
| L03AB11 |
Peginterferon alfa-2a |
Pegasys |
Solution for injection |
180 mcg/0,5 ml |
|
1 pre-filled pen |
Roche Registration Limited, Обединено Кралство |
26 |
mсg |
323.4 |
46.73121 |
323.38 |
100% |
|
Съгласно РУ |
КЦРР-960/16.07.2012 г.; НСР-437/09.07.2013; НСР-5935/01.04.2015.; НСР-12433/18.04.2017 |
02.06.2017 |
08.09.2012 |
Заличен |
3771 |
| L03AX03 |
Mycobacterium bovis BCG (Baccilus Calmette - Guerin) |
L03AX03 Mycobacterium bovis BCG (Baccilus Calmette - Guerin) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AX03 |
Mycobacterium bovis BCG |
CALGEVAX |
Powder for suspension |
11.25 mg |
|
4 |
БУЛ БИО-НЦЗПБ ЕООД, България |
1 |
mg |
149.76 |
3.328 |
149.76 |
100% |
|
Съгласно РУ |
НСР-8254/22.02.2016 |
02.01.2017 |
|
Активен |
4210 |
| L03AX03 |
Mycobacterium bovis BCG |
CALGEVAX |
Powder for suspension |
11.25 mg |
|
10 |
БУЛ БИО-НЦЗПБ ЕООД, България |
1 |
mg |
208.42 |
1.85262 |
208.42 |
100% |
|
Съгласно РУ |
КЦРР-1251/15.08.2012 г.; НСР-11090/01.12.2016 |
02.01.2017 |
08.09.2012 |
Заличен |
1343 |